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Abstract
 
Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which
they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal
and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids
402–410 of the C
 
 
 
3 domain of dimeric IgA (dIgA) represented a potential binding site for the
pIgR. Here by binding human secretory component to overlapping decapeptides of C
 
 
 
3, we
confirm these residues and also uncover an additional site. Furthermore, we show that the C
 
 
 
3
motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-
specific cellular transcytosis system. An alternative approach identified phage peptides, selected
from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated
transport through epithelial cells. Some transcytosis-selected peptides map to the same 402–410
pIgR-binding C
 
 
 
3 site. Further in vivo studies document that at least one of these peptides is
transported in a rat model measuring hepatic bile transport. In addition to identifying small
peptides that are both bound and transported by the pIgR, this study provides evidence that the
pIgR-mediated mucosal secretion system may represent a means of targeting small molecule
therapeutics and genes to mucosal epithelial cells.
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Introduction
 
The humoral mucosal immune system is well adapted to
deliver protective antibody to the mucosal surface where it
prevents entry of a variety of pathogens to the body (1). A
unique pathway exists within these tissues to specifically
transport and secrete polymeric immunoglobulins, including
polymeric IgA, at mucosal sites where they can act against
microbial infection (2). Dimeric IgA (dIgA) binds specifically
to the polymeric Ig receptor (pIgR), which is present on
the basolateral surface of mucosal epithelial cells. The dIgA
is subsequently endocytosed and transported across the cell
to be secreted at the opposing apical cell surface as secretory
IgA (sIgA). Through this process, sIgA retains most of the
extracellular region of the pIgR, termed secretory component
(SC; references 3–5). The pIgR-mediated transcytosis
pathway for dIgA therefore provides an ideal mechanism to
exploit for the specific delivery of drugs, antibodies, viruses,
and genes to mucosal or glandular epithelial cells. The goal
of the current study was to identify small peptide motifs
that would both bind to the pIgR and be specifically
transcytosed by the receptor and thus offer the possibility
of targeting mucosal sites.
 
Materials and Methods
 
Solid-Phase Decapeptide Assay.
 
The amino acid sequence of
human IgA1 was used to construct decapeptides overlapping by
eight amino acids from the C
 
 
 
3 domain of human IgA as described
previously (6). The overlapping decapeptides were simultaneously
synthesized at the rounded ends of radiation derivatized polyethyl-
ene pins, arranged to fit into the wells of 96-well microtiter plates
(Chiron Mimotopes). Positive control pins were synthesized
from a known reactive sequence of the Sm B’ protein (6). The
identification of C
 
 
 
3 reactive decapeptides was performed using
a modified ELISA-based assay. Briefly, pins were blocked with
3% low-fat milk in PBS, pH 7.4 for 1 h at room temperature.
After each step of the assay, pins were washed four times for 8
min in PBS with 0.05% Tween. Pins were first incubated with
100 
 
 
 
l/well of purified SC. Next, the pins were incubated with
100 
 
 
 
l/well of 1:500 sheep anti–rabbit SC (provided by Dr.
Keith Mostov, University of California at San Francisco, San
Francisco, CA) overnight at 4
 
 
 
C, followed by incubation with
100 
 
 
 
l/well 1:1,000 donkey anti–sheep IgG conjugated to alkaline
phosphatase (Sigma-Aldrich) for 2–3 h at room temperature. The
negative control assay to rule out reagent reactivity included all
steps except incubation with SC. The positive control pins were
tested with a known concentration of a standard control patient
sera (provided by Dr. Judith James, Oklahoma Medical Research
Foundation, Oklahoma City, OK). Paranitrophenyl phosphate
was used as substrate and microtiter plates were read at 405 nm
with a SpectraMax Plus Reader (Molecular Devices) until the
positive control wells reached an OD of 
 
 
 
2.0. Results for each
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plate were normalized by comparison with the positive control
pins. After completion of each assay, the pins were regenerated as
described previously (6).
 
Baculovirus Expression of Human Secretory Component.
 
The hexa-
histidine-tagged extracellular region of human pIgR (reference 7;
provided by Dr. Jean-Pierre Kraehenbuhl, University of Lausanne,
Lausanne, Switzerland) was cloned into the pH-360EX baculovi-
rus transfer vector using standard molecular biology techniques
(8). Transfer vector containing pIgR was cotransfected with
Bsu36I-digested BacPAK6 viral DNA using Bacfectin (CLON-
TECH Laboratories, Inc.) into 
 
Spodoptera frugiperda
 
 cells (Sf9) to
produce recombinant virus. Growth, plaque purification, and
amplification of recombinant virus were standard. For protein
production, High Five cells (Invitrogen) infected at an MOI of 5
were maintained in serum free medium in shaking flasks at 2 
 
 
 
10
 
6
 
 cells/ml. Human SC was then purified from cell supernatants
on Ni-NTA agarose columns (QIAGEN) and dialyzed to PBS.
Quantification was performed using Ni-NTA HisSorb plates
(QIAGEN).
 
Cell Culture.
 
Type II Madin Darby Canine Kidney
 
 (
 
MDCK)
cells and Type II MDCK cells stably transfected with rabbit pIgR
(provided by Dr. Keith Mostov, University of California at San
Francisco) were maintained in DMEM containing 5–10% fetal
bovine serum (HyClone Laboratories) and antibiotics in 5% CO
 
2
 
at 37
 
 
 
C (9). For transcytosis assays, transfected or nontransfected
MDCK cells were grown to confluence in 6-well plates on 0.45
or 1.0 
 
 
 
m pore size Falcon cell culture inserts (BD Biosciences;
reference 9). The cells were fed every other day and used for the
various transcytosis assays 4 to 5 d after plating.
 
Construction of Green Fluorescent Protein Fusion Peptides.
 
Monomeric (TWASRQEPSQGTTTFAVTSGP (G)
 
6
 
PG-GFP) and
dimeric (TWASRQEPSQGTTTFAVTSGP(G)
 
6
 
PGPGTWASR-
QEPSQGTTTFAVTSGP(G)
 
6
 
PG-GFP) IgA pIgR-binding
peptides and the corresponding monomeric IgG peptide (TTP-
PVLDSDGPFFLYSGP(G)
 
6
 
PG-GFP) were cloned into the high
level bacterial green fluorescent protein (GFP) expression vector
pQBI T7-GFP (Quantum Biotechnologies) with a small linker
sequence, resulting in NH
 
2
 
-terminal peptide fusions. Bacterial
expression was induced with IPTG and crude protein extracts
generated by standard freeze-thaw methods. The peptide fusion
proteins were analyzed by SDS-PAGE and by Western blot with
detection using GFP monoclonal antibody (Quantum Biotech-
nologies). The amounts of GFP fusion proteins were normalized
by measuring Absorbance at 590 nm on an fmax fluorescence
plate reader (Molecular Devices).
 
pIgR-mediated Transport of GFP Fusion Peptides.
 
GFP fusion pro-
teins were added to the basolateral chamber of polarized MDCK
cells or pIgR-transfected MDCK cells grown on 0.45 
 
 
 
m cell
culture inserts. After 4 h of incubation at 37
 
 
 
C, the apical media
was collected and GFP fluorescence determined.
 
Selection of Random Phage Peptide by Transcytosis.
 
The random
40-mer peptide library RAPID 40 (DGI Biotechnologies) with a
total diversity of 1.55 
 
 
 
 10
 
10
 
 has been described previously (10).
A similar 20-mer random peptide library was also used (provided
by Dr. Stephen Johnston, The University of Texas Southwestern
Medical Center, Dallas, TX; reference 11). For phage selection,
100 library equivalents were added to the basolateral chamber of
polarized pIgR-transfected MDCK cells grown on 1.0 
 
 
 
m cell
culture inserts. After 4 h of incubation at 37
 
 
 
C, the apical media
was harvested. Phage rescue and amplification were performed in
 
Escherichia coli
 
 strain TG1 according to standard procedures (12).
After eight rounds of selection, random phage clones were se-
lected and propagated for sequencing.
 
DNA Sequencing and Analysis.
 
DNA sequencing was per-
formed on double-stranded plasmid or phagemid DNA using an
ABI 377 Prism automated sequencer. Alignments of deduced
peptide sequences with immunoglobulin constant regions were
performed using the program LALIGN (13).
 
pIgR-Mediated Transport of Selected Phage Peptides.
 
5 
 
 
 
 10
 
10
 
 phage
particles were added to the basolateral chamber of polarized
MDCK cells or pIgR-transfected MDCK cells grown on 1.0-
 
 
 
m
cell culture inserts. After 4 h of incubation at 37
 
 
 
C, the apical
media was collected and the titers of transported phage were de-
termined.
 
Rat Transport Experiments.
 
Male Wistar rats were anesthe-
tized with ketamine hydrochloride, an I.V. saline line established,
and the bile duct cannulated with the outlet of the cannula situ-
ated below the rat. Bile collection began after I.V. injection of
10
 
6
 
 test phage and 10
 
6
 
 negative control phage particles (in 0.2 ml
PBS) and was continued for 3.5 h, collecting bile at 30 min time
points in separate tubes. After bile collection was complete, the
animals were killed. Phage titers were determined and 20 random
phage clones were sequenced from each time point. Experiments
were performed in accordance with institutional guidelines for
animal care and use.
 
Results and Discussion
 
We previously reported the localization of an important
pIgR-binding site on dimeric human IgA to a predicted loop
structure in the C
 
 
 
3 domain (10). To further localize this in-
teraction, the binding of pIgR to overlapping decapeptides
comprising C
 
 
 
3 was evaluated. When the C
 
 
 
3 decapeptides
bound to pins were screened for reactivity with the polyclonal
anti-SC serum and anti–sheep IgG conjugate, no significant
background was demonstrated (Fig. 1 a). However, screening
the peptides with SC identified two pIgR-reactive regions
within the sequence of C
 
 
 
3, peptide numbers 35–36 and 48–
50 (Fig. 1 b). Decapeptide numbers 35–36 correspond to
amino acids 404–415 of C
 
 
 
3 and decapeptides 48–50 corre-
spond to amino acids 430–443. Previous phage display selec-
tion of random peptides with cell-expressed pIgR coupled
with subsequent alanine substitution provided evidence for
amino acids 402–410 of C
 
 
 
3 in dIgA being involved in the
interaction with pIgR (10). The current results for decapep-
tides 35–36 correspond to the same region in C
 
 
 
3 and thus
provide further evidence for the importance of this specific in-
teraction. When the region of C
 
 
 
3 identified by decapeptides
48–50 (C
 
 
 
3 amino acids 430–443) are compared with the
corresponding region of C
 
 
 
3 (amino acids 424–437), part of
the region would be predicted to form a loop structure and
thus be accessible for ligand binding based on the crystal struc-
ture of IgG Fc (14). Therefore, amino acids 430–443 of C
 
 
 
3
may represent another part of dIgA that cooperates with the
402–410 amino acid region for the initial high affinity interac-
tion of dIgA with pIgR.
To identify a motif on IgA dimer molecules or unique
peptide motifs that lead to secretion onto mucosal surfaces
via the pIgR-mediated transcytosis pathway, experiments
were designed to localize the smallest possible peptide(s) re-
quired for the pIgR–dIgA interaction. The native region
from IgA (amino acids 402–410) that we have shown pre- 
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viously to be involved in pIgR-binding was synthesized in
both monomeric (mApep) and dimeric (dApep) form with
a small linker as GFP fusion proteins. As a negative control,
the corresponding region from C
 
 
 
3 (amino acids 398–403)
was also synthesized as a fusion protein in monomeric form
(mGpep). The ability of mApep, dApep, and mGpep to be
specifically transported by the pIgR was assessed in the
MDCK transcytosis assay by using both pIgR-transfected
and nontransfected cells (Fig. 2). The data indicate that a
peptide derived from the native region from the CH3 re-
gion of IgA in dimeric form, and to a lesser extent in mo-
nomeric form, can indeed direct transport of a fusion pro-
tein through pIgR-transfected MDCK cells but not
through nontransfected MDCK cells. mGpep, the negative
control peptide derived from the sequence of IgG, was not
transported by the pIgR.
It is conceivable that other structures, including smaller
peptides, could substitute for polymeric immunoglobulins
in the pIgR-mediated transcytosis process. To identify such
molecules, the MDCK transcytosis system was used to se-
lect random phage-displayed peptides transcytosed in vi-
tro. Three independent MDCK-pIgR transcytosis system
phage display selection experiments were performed. Two
experiments used a 40-mer random peptide library (experi-
ments no. 1 and no. 2) and one experiment used a 20-mer
random peptide library (experiment no. 3). Both phage li-
braries were constructed as pIII peptide fusions as this re-
sults in low number of peptides per phage being expressed
and thus should allow selection of high affinity interactions.
After eight rounds of selection, 20 clones from experiment
no. 1 and 18 clones from experiments no. 2 and no. 3 were
chosen at random and sequenced. Shown in Fig. 3 are the
eight phage peptides selected from the three experiments
and the frequency of selection of each phage clone.
Figure 1. Reactivity of human pIgR with C 3 decapeptides overlapping
by eight amino acids. (a) Background reactivity of the decapeptides with
pIgR detection reagents sheep anti-pIgR and donkey anti–sheep IgG alone.
(b) Interaction of the decapeptides with human SC detected with sheep
anti-pIgR and donkey anti–sheep IgG alkaline phosphatase. Results are
means from three assays.
Figure 2. Transcytosis of GFP fusion proteins through nontransfected
and pIgR-transfected MDCK cells. The native region from dIgA (amino
acids 402–410) that was previously identified to be involved in pIgR-
binding has been synthesized in both monomeric (mApep) and dimeric
(dApep) form as GFP fusion proteins. The corresponding region from
IgG that does not bind to the pIgR was also synthesized in monomeric
form as a negative control (mGpep). The ability of the GFP fusion proteins
to be specifically transported by the pIgR in the MDCK transcytosis system
was assessed by measuring fluorescence from the apical medium after the
MDCK transcytosis assay was performed using both nontransfected
(shown as solid fill) and pIgR-transfected (shown as no fill) cells. Results
represent means of three assays.
Figure 3. Phage peptides selected by transcytosis and frequency of
selection. The in vitro MDCK-pIgR transcytosis system was used to
identify phage peptides that were transported from the basolateral medium
to the apical medium. Two experiments used a 40-mer random peptide
library (experiments no. 1 and no. 2) and one experiment used a 20-mer
random peptide library (experiment no. 3). Phage peptides are referred
to by the first three amino acids of their sequence. 
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When the eight selected phage peptides were aligned to
the sequence of IgA, three peptides (VDD, SAM, and IPS)
show significant identity in and around the 402–410 region
which we have previously shown to be important for pIgR
binding (Fig. 4). The SAM peptide shares 41.2% identity in
a 17 amino acid overlap with IgA, the VDD peptide has
40.9% identity in a 22 amino acid overlap, and the IPS
peptide has 31.8% identity with IgA in a 22 amino acid
overlap. In addition, several of the peptides show high ho-
mology to sequences within J chain (unpublished data), are
currently under further investigation, and will subsequently
be submitted for publication. The use of the RAPID 40
phage library has been recently reported for the identifica-
tion of protein partners (15). As a negative control, the
peptide sequences were aligned with irrelevant proteins
such as human serum albumin and do not show significant
homology (unpublished data). Identity values for the pep-
tides compared with albumin do not exceed 20.0% in an
average of 18 amino acid overlap. When the peptide se-
quences were compared with each other using peptide
alignment computer programs, no common sequence mo-
tifs were found.
Eight phage peptides were selected for their positive
transport through epithelial cells expressing pIgR. How-
ever, the definitive mechanism of transport was not deter-
mined. Therefore, the movement of the phage peptides
through both pIgR-transfected and nontransfected MDCK
cells was measured. The results indicate that the RSR,
SAM, IPS, VDD, QRN, and MFV peptides displayed on
the surface of the phage allow the phage to be selectively
transported by the pIgR through MDCK cells (Fig. 5, a–c).
In contrast, the WQA and LVL phage peptides likely direct
apical transport of phage by an alternate transcytosis path-
Figure 4. Three phage peptides
selected by transcytosis map to
C 3 of human IgA. The transcy-
tosis-selected phage peptides
were aligned to the sequence of
IgA using the computer program
LALIGN. The symbol :   amino
acid identity and the symbol .  
amino acid similarity.
Figure 5. Basolateral to apical trans-
port of phage peptides measured in the
MDCK transcytosis system. Phage were
added to the basolateral medium of wells
containing 1.0  m pore inserts confluent
with either polarized nontransfected
(negative control shown as solid fill) or
pIgR-transfected (shown as no fill)
MDCK cells. Transcytosis was allowed
to occur for 4 h. The apical supernatant
fluids were collected and phage titers
determined. (a) Transport of RSR and
SAM peptides; (b) transport of IPS and
VDD peptides; (c) transport of QRN
and MFV peptides; and (d) transport
of WQA and LVL peptides. Results
represent means from three independent
experiments.
Figure 6. Kinetics of IPS phage peptide secretion into rat bile. The bile
ducts of male Wistar rats were cannulated. Bile collection began after I.V.
injection of 106 specific phage (IPS) and 106 negative control phage particles
and was continued for 30 min time points in separate tubes. Phage titers from
each time point were determined by standard procedures. 
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way as there is no difference in transport by MDCK cells
whether they are transfected with pIgR or not (Fig. 5 d).
To determine if the phage-displayed peptides are trans-
ported in vivo, a mixture of pIgR transcytosis-selected IPS
phage and nonspecific phage were injected intravenously
into rats. Bile was collected at 30 min time intervals to
measure hepatic transport. The kinetics of IPS phage trans-
port were similar to that reported previously for dIgA (16;
Fig. 6). 100% of the phage recovered from all time points
displayed the IPS peptide (unpublished data). No nonspe-
cific phage were recovered at any time point (unpublished
data). Therefore, at least one of the phage peptides identi-
fied by in vitro transcytosis is transported specifically by the
pIgR in vivo in a rat model for pIgR transport.
This study aimed to identify structural determinants, ei-
ther derived from the sequence of dIgA Fc or dIgA-inde-
pendent, required for interaction with the highly specific
pIgR-mediated transcytosis pathway for the secretion of
polymeric immunoglobulins onto mucosal surfaces. With
this information, it may be possible to exploit the IgA-spe-
cific pIgR mucosal secretion system as a means of targeting
therapeutic recombinant molecules and/or genes to mu-
cosal epithelial cells or their surfaces. We previously identi-
fied a nine amino acid structural motif in the C
 
 
 
3 domain
of IgA that is important for binding of dIgA to the pIgR.
This motif, when expressed as a monomer, but especially
when expressed as a dimer appears to be sufficient to direct
transport of the 23-kD GFP fusion protein through the
pIgR-specific cellular transcytosis system. In addition, we
have selected a number of phage peptides that are transcy-
tosed by pIgR using an in vitro transcytosis assay with
pIgR-transfected MDCK cells and phage display tech-
niques. Three of the peptides show considerable homology
with the native pIgR-binding region of dIgA, four have
significant homology with human J chain, and some bear
no resemblance to the IgA constant region sequence. Inter-
estingly, six of the eight selected peptides appear to be spe-
cifically transported by the pIgR while two appear to be
transported through MDCK cells via an alternate pathway.
In vivo studies indicate that at least one of the peptides, IPS,
is transported by the pIgR in the rat. Therefore, the results
of this study validate the feasibility of using a small pIgR-
binding motif to deliver therapeutics to mucosal sites. Fur-
thermore, tissue-specific mucosal epithelial cells may dis-
play unique receptor molecules, which can be identified by
random peptide selection upon live cells. Linking structures
specific for the pIgR with additional tissue antigens may
yield molecules of high avidity capable of the selective or
site-specific delivery of a variety of therapeutic molecules.
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